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Abstract 
Ethnopharmacological relevance:  
Traditional Chinese Medicine (TCM) has many obvious advantages in the treatment of 
chronic conditions such as urinary tract infection (UTI). Dongbai-Tonglin-Fang 
(DBTL), a Chinese herbal formula, has been used for the treatment of UTI for more 
than 40 years with proven efficacy. However, its mechanism of action is still unknown. 
Aim of the study:  
The purpose of this study is to evaluate the therapeutic efficacy of DBTL and its 
mechanism of action in a rat UTI model.  
Materials and methods:  
E. coli solution induced UTI rat model was used to evaluate the therapeutic effect of 
DBTL on UTI. Biochemical indicators related to UTI were measured. The kidney tissue 
was stained with hematoxylin-eosin (HE) to observe pathological changes whilst the 
ear swelling, feet swelling, hot plate and body torsion tests were used to estimate the 
anti-inflammatory and analgesic effects of DBTL.  
Results:  
After treatment with different doses of DBTL (1, 2, 4 g/kg), a decrease in weight of the 
kidney in the UTI rat model was observed. The contents of white blood cell, nitrite, 
urinary albumin, ketone body, bilirubin and occult blood in the urine were also reduced 
whilst an increase in the pH of urine was observed. HE staining showed that the 
pathological changes in the kidney tissue were alleviated. At the same time, 
ear swelling assay showed that the weight and the degree of swelling of the ear of the 
mice in DBTL groups were decreased remarkably. DBTL also reduced the degree of 
feet swelling of the rats caused by the adjuvant. Furthermore, with the DBTL treatment, 
the latency period of foot licking induced by thermal stimulation was increased while 
the number of twists was lessened. 
Conclusion:  
These results show that DBTL has an excellent therapeutic effect on UTI rats 
accompanying with anti-inflammation and analgesia. The data presented here lays the 
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1. Introduction 
Urinary tract infections (UTI) refer to the inflammation of urinary system caused by the 
reproduction of a large number of microorganisms in the urethra, of which the bacterial 
infection is the most common. Its main clinical symptoms include frequent urination, 
urgent urination, urinal pain, purulent urine, fever, chills, pain in the waist and flank, 
and percussion pain in the kidney area. Due to the different sites and symptoms of 
infection, it can be divided into upper urinary tract infections (mainly pyelonephritis) 
and lower urinary tract infections (mainly cystitis and urethritis). This disease is a 
common multiple disease, ranking second only to respiratory tract infections. Its 
incidence rate in China accounts for 0.91% of the total population and moreover it tends 
to occur in women (Dong and Ye, 2003; Pu Yan, 2017; Stamm and Norrby, 2001; Yang, 
H. et al., 2018). About 50% of women have at least one UTI in their lifetime. More 
significantly, UTI is dangerous in infants and children because it can lead to kidney 
disease thus endangering lives. It can also elevate the risk of pyelonephritis, premature 
delivery, and fetal mortality among pregnant women, and is also associated 
with impaired renal function and end-stage renal disease among pediatric patients 
(Bjornsdottir et al., 1998; Foxman, 2003).  
UTI belongs to the category of drench syndrome in Traditional Chinese Medicine 
(TCM) which has great advantages in the treatment of this diseaseas it displays multiple 
target sites  and has  integrity, and little toxic and side effects (Yang and Mai, 2012). 
TCM can also significantly reduce the frequency of recurrence of this disease and 
further investigation in the mechanism of action of TCM for the treatment of UTI can 
provide more effective guidance for its use in clinical practice (Yang and Mai, 2012).  
Dongbai-Tonglin-Fang (DBTL), a Chinese herbal formula, is a hospital preparation of 
Shanghai Seventh’s Hospital, and has a history of more than 40 years for the treatment 
of treating UTI (Dai et al., 2017; Shi et al., 2014; Sun, 2008; Yang and Ye, 2010; Zhu 
et al., 2018; Zhu, 1995). DBTL is composed of 8 herbs, namely Phellodendron chinense 
C.K. Schneid. (Rutaceae), Lonicera japonica Thunb. (Caprifoliaceae), Dianthus 
superbus L. (Caryophyllaceae), Polygonum aviculare L. (Polygonaceae), Lindera 
aggregata (Sims) Kosterm. (Lauraceae), Plantago depressa Willd. (Plantaginaceae), 
Citrus reticulata Blanco. (Rutaceae) and Glycyrrhiza uralensis Fisch. (Leguminosae 
sp.), as shown in Table 1. Among these herbs, Phellodendron chinense C.K. Schneid. 
has damp-drying, heat-clearing, and detoxifying effects. In addition, it is also used 
clinically for conditions such as dampness-heat diarrhea, jaundice, hot drench, 
hemorrhoids, night sweats, spermatorrhea etc. (Li et al., 2014). Lonicera japonica 
Thunb. can clear heat and can detoxicate (Zhang et al., 2009). Dianthus superbus L.  
and Polygonum aviculare L. are effective as diuresis inducers for the treatment of 
stranguria (Liu, 2011; Yang et al., 2016). Lindera aggregata (Sims) Kostermis reported 
to warm the kidney and regulates Qi and relieves pain (Xing et al., 2017). Citrus 
reticulata Blanco. can regulate Qi, remove dampness and strengthen the spleen (Zhao, 
2013). Plantago depressa Willd. can dissipate the heat, and displays diuretic and 
detoxification properties (Yang et al., 2011). Glycyrrhiza uralensis Fisch. invigorates 
the spleen, replenishing Qi, clearing away heat and displays detoxicating potential 
(Yang, M. et al., 2018).  Thus this formula is excellent treating UTI, and is very popular 
among patients. 
Herein, DBTL was administered in the rat-induced UTI model with E. coli solution. At 
the same time, ear swelling assay, feet swelling assay, hot plate assay, and body torsion 
assay were used to estimate the anti-inflammatory and analgesic effect of DBTL.  
 
Table 1. The composition of  Dongbai-Tonglin-Fang (DBTL) 
Scientific name Chinese name Weight (g) Ratio (%) 
Phellodendron chinense C.K. Schneid. (Rutaceae) Huangbai 12 8.11 
Lonicera japonica Thunb. (Caprifoliaceae) Rendongteng 40 27.03 
Dianthus superbus L. (Caryophyllaceae) Qumai 24 16.22 
Polygonum aviculare L. (Polygonaceae) Bianxu 24 16.22 
Lindera aggregata (Sims) Kosterm. (Lauraceae) Wuyao 12 8.11 
Plantago depressa Willd. (Plantaginaceae) Cheqiancao 24 16.22 
Citrus reticulata Blanco. (Rutaceae) Chenpi 8 5.40 
Glycyrrhiza uralensis Fisch. (Leguminosae sp.) Gancao 4 2.70 
Total amount 8 148 100 
 
2. Materials and methods 
 
2.1. Preparation of DBTL 
 
The 8 herbs of DBTL were purchased from Shanghai Kangqiao Chinese herbal pieces 
co., LTD. All the herbs were prepared in proportion by soaking in 10 times their weight 
in pure water and were then extracted three times by refluxing for 1 h. This solution 
was then filtered and the filtrate concentrated, to a thick paste with a relative density of 
1.25-1.34 (80 ℃).  
 2.2. HPLC/ESI-MS and fingerprint analysis 
 
An Agilent 1100 HPLC system, equipped with a quaternary pump, an autosampler, a 
degasser, an automatic thermostatic column compartment, a DAD and an LC/MSD 
Trap XCT ESI mass spectrometer (Agilent Technologies, MA, USA), was used for the 
separation of the constituents of DBTL. The separation was performed on a GS-120-5-
C18-BIO chromatographic column (5 m, 250  4.6 mm i.d.) with the column 
temperature set at 35C. A linear gradient elution of A (0.1% formic acid water) and B 
(acetonitrile) was used with the gradient procedure as follows: 0 min, B 5%, to 60 min 
B 40% (v/v). The flow rate was 1.0 mL/min and the injection volume was 10 L. DAD 
was on and the target wavelength was simultaneously set at 210 nm the split ratio to the 
mass spectrometer was 1:3. The acquisition parameters for negative ion mode were: 
collision gas, ultra high-purity helium (He), nebulizer gas (N2), 35 psi, drying gas (N2), 
10 L/min, drying temperature, 350°C, HV, 3500 V, mass scan range, m/z 100-2200, 
target mass, 500 m/z, compound stability, 100%, trap drive level, 100%. All the data 
were analysed by Chemstation software. 
 
2.3. Establishment of UTI model in rats and Animal treatment  
 
Male Sprague Dawley (SD) rats were obtained from Shanghai Xipul-Bikai 
Experimental Animal Co., Itd.. As reported (Hou et al., 1998), the rats were denied 
access to water for 18 hours, and were then anesthetized by intraperitoneal injection of 
10% chloral hydrate. An incision of approximately 2 cm was made in the middle of the 
lower abdomen of the rats and the left posterior abdominal wall was exposed and the 
left ureter identified. Following this the angle pin of 4# thread was inserted from both 
sides of the middle part of the ureter to the lateral side of the posterior abdominal wall 
respectively. The bladder was then exposed and the penis was closed with an arterial 
clamp. The 5# syringe containing 0.75 ml of the prepared 1x105/mL escherichia coli 
bacteria (ATCC25922) solution was inserted into the bladder slowly. Both ends of the 
silk thread on the outside of the abdominal wall were then tightened. And the ureter 
was ligated with appropriate tightness. At last, the abdominal cavity was cleaned and 
the wound was stitched. 20 h later, the ligation line of the ureter outside the abdominal 
wall was removed to re-open the ureter. For the normal control group, 10 SD rats had 
their abdominal cavity opened in the same way, without any treatment, and both groups 
were allowed access to water and food. The compound to be tested was intragastricly 
administered consecutively for 7 days. 
The rats were divided into normal control group, model control group, positive control 
groups (0.05 g/kg levofloxacin tablets and 0.348 g/kg Sanjin tablets), DBTL-L group 
(1 g/kg), DBTL-M group (2 g/kg), and DBTL-H group (4 g/kg), each group contained 
10 animals. Urine collection began an hour after the last administration for urine 
bacterial culture and routine urine examination. The rats were then sacrificed by 
cervical dislocation, kidneys were removed, weighed and kidney tissure prepared for 
hematoxylin-eosin (HE) staining for pathological examination. 
 
2.4 Inflammation models and Animal treatment  
 
2.4.1 Ear swelling assay 
 
Fifty mice were divided into model control group, positive control group (0.36 g/kg, 
aspirin), and DBTL groups (1, 2, and 4 g/kg). Mice were orally administered daily for 
one week and 1 hour after the last dose, mice were treated with 0.1 mL xylene on both 
sides of the right ear, and the left ear was used as a normal control. After a further 1h, 
the mice were anesthetized by 3% chloral hydrate and their ears were cut along the 
baseline of auricle, then punched down with the round piece in the same part of the left 
and right ear with a ear piercer, weighed and the degree of inhibition rate of ear swelling 
calculated as shown below. 
Inhibition rate = (right ear weight / left ear weight) / left ear weight *100. 
 
2.4.2 Feet swelling assay 
 
Fifty male rats were divided into model control group, positive control group (0.36 g/kg, 
aspirin), and DBTL groups (1 g/kg, 2 g/kg, and 4 g/kg). The oral gavage was performed 
daily for a week and 1 h after the last administration, 0.1 mL adjuvant was injected into 
the right posterior foot plantar fascia of rats to induce inflammation. The diameter of 
the right posterior foot was measured by vernier caliper every 1 hour before and 1-6 h 
post-inflammation. 
 2.5 Establishment of pain model in mice and Animal treatment  
 
2.5.1 Body torsion assay 
 
Fifty mice were divided into model control group, positive control group (0.36 g/kg, 
aspirin), and DBTL groups (1 g/kg, 2 g/kg, and 4 g/kg). The oral gavage was performed 
daily for a week and 1 h after the last administration, 0.7% glacial acetic acid was 
injected intraperitoneally (10 mL/kg). Meanwhile the number of torsions (including 
abdominal contraction and coved, stretched the hind legs, raised hip, crawl) within 15 
minutes after administration were recorded in each group.            
                                   
2.5.2 Hot plate assay 
 
A water bath was heated to a constant temperature of 55 ± 0.5℃, the bottom of the 
beaker touched the water and was heated by thermal stimulation. A stopwatch was used 
to record the time between mice being placed on the hot plate to the time they appeared 
to lick their feet as exceeding the threshold of pain. The female mice were placed on 
the hotplate and the pain threshold was measured three times. The licking of the feet 
was regarded as pain response index and those mice displaying a pain response of 30 
seconds were selected. A total number of 50 mice were selected. 
The selected mice were divided into model control group, positive control group (0.36 
g/kg, aspirin), and DBTL groups (1 g/kg, 2 g/kg, and 4 g/kg). The oral gavage was 
performed daily for one week and 1 h after the last administration, the mice were placed 
in a constant temperature beaker (55 ± 0.5 °C), room temperature was 20.0 ± 1 °C, and 
the time taken to perform the first licking of feet was recorded in each group. 
2.6 Statistical analysis 
 
The results are expressed as means ± standard deviation (SD). Analysis of variance 
(ANOVA) and Kruskal-wallis H test was used to test the significance of the difference. 
All statistical analyses were two-sided and performed using the Statistical Package for 
the Social Sciences software version 17.0 (SPSS, Inc., Chicago, IL, USA). A p-value < 




The experiments were carried out in accordance with the guidelines issued by the 
Experimental Animal Ethical Committee of Seventh People's Hospital of Shanghai 




3.1 Identification of ten compounds in DBTL 
 
The aqueous extract of the mixture of 8 Chinese medicinal materials was separated by 
high-performance liquid chromatography coupled with electrospray mass spectrometry 
(HPLC/ESI-MS) in negative and positive-ion mode (Fig. 1). Ten compounds 110 (Fig. 
Sl), with the retention time of 0.74 min, 7.40 min, 7.71 min, 9.29 min, 10.62 min, 11.63 
min, 12.81 min, 16.27 min, 8.34 min, and 9.62 min respectively, were identified as 
phellodendrine (1), isochlorogenic acid (2), methyl chlorogenate (3), gycycoumarin (4), 
myricitrin (5), naringin (6), hesperidin (7), glycyrrhizin (8), isocorypalmine (9), 
and  norboldine (10), on the basis of the observation of the pseudomolecular ion peak 
at m/z 377.0924 [M  Cl] (1), m/z 353.0908 [M  H] (2), m/z 367.1064 [M  H] (3), 
m/z 367.1094 [M  H] (4), m/z 463.0915 [M  H] (5), m/z 579.1761 [M  H] (6), m/z 
609.1894 [M  H] (7), m/z 821.4018 [M  H] (8), m/z 342.1737 [M  H] (9), m/z 
314.1762 [M  H] (10), in HPLC/ESI-MS chromatogram, in accordance with the 
molecular weights of ten compounds (phellodendrine, isochlorogenic acid, methyl 
chlorogenate, gycycoumarin, myricitrin, naringin, hesperidin, glycyrrhizin, 
isocorypalmine, and  norboldine). A total of 10 compounds were unambiguously 





Fig. 1. HPLC/ESI-MS chromatogram of the aqueous extract in negative and positive mode. 
 3.2 DBTL reduced the kidney weight in UTI rats 
 
The changes in kidney weight in rats were measured to evaluate the effect of DBTL on 
UTI rats are shown in Fig. 2. The kidneys of rats in model group were much heavier 
than those from the normal control group (p < 0.05). After treating with Levofloxacin, 
Sanjin tablets, and DBTL, the kidney weight was decreased significantly (p < 0.05). 
This reduction in kidney weight is positively correlated with the dose of DBTL. 
  
Fig. 2. DBTL reduced the kidney weight in UTI rats. The changes of left and right kidney weight in rats 
were measured in the model group, normal control group, Levofloxacin group, Sanjin tablets group, and 
DBTL groups. *p<0.05, **p<0.01, ***p<0.001 versus model group, ###p<0.001 versus control group, n=10. 
 
3.3 DBTL improved the biochemical indicators in UTI rats  
 
To evaluate the effect of DBTL on UTI rats, biochemical indicators were measured, 
and the results of these were presented in Fig. 3. Compared with the normal control 
group, the pH value was decreased significantly in UTI model group (p < 0.05) and the 
pH value was increased after treating with Levofloxacin, Sanjin tablets, and DBTL (Fig. 
3a). Besides, in UTI rats, the contents of white blood cell (WBC), nitrite, urinary 
albumin, ketone body, bilirubin and occult blood in urine were higher than that present 
in the normal control group. In contrast, a significant dose dependent reduction in these 
parameters was observed after treatment with Levofloxacin, Sanjin tablets, and DBTL 
(Fig.3b-3g) (p < 0.05). Bacteria were detected in the urine of the model group. However, 
no bacteria were confirmed in the urine of normal control, Levofloxacin, Sanjin tablet, 
and DBTL groups. 
 
Fig. 3. DTG improved the biochemical indicators in UTI rats. The pH value, the contents of white blood 
cell, nitrite, urinary albumin, ketone body, bilirubin and occult blood were detected in the model group, 
normal control group, Levofloxacin group, Sanjin tablets group, and DBTL groups. *p<0.05, **p<0.01, 
***p<0.001 versus model group, ###p<0.001 versus control group, n=10. 
 
 
3.4 DBTL improved the abnormal histology in UTI rats 
 
The changes in the pathology of renal tissues were observed by histology after staining 
with H&E. As shown in Fig. 4, there were no inflammatory cells found in renal tissue 
of rats in the normal control group. While in the UTI model control group, mucosa 
degeneration, necrosis, apoptosis, shedding with visible edema and a large number of 
infiltrated inflammatory cells were present in the renal tissues together with pus pellets. 
The renal tissue lesions were ameliorated after treating with Levofloxacin, Sanjin 
tablets, and DBTL. However, there was a small amount of mucosa apoptosis, 




Fig. 4. Histological images of renal tissues stained with H& E. a. model group, b. normal control group, 
c. Levofloxacin group, d. Sanjin tablets group, e. DBTL-L group, f. DBTL-M group, g. DBTL-H group. 
(original magnification × 400), n=10. 
 
 
3. 5 DBTL relieved pain in mice  
 
The effects of DBTL on body torsion induced by glacial acetic acid and hot plate 
reaction in mice are shown in Fig. 5a and 5b. The number of twisting induced by glacial 
acetic acid in administration groups was decreased significantly compared with the 
model group (P < 0.01 & P < 0.05). The incubation period of the licking feet time 
induced by hot plate was sharply increased in a dose-dependent manner after treatment 
with aspirin and DBTL.  
 
3. 6 DBTL resisted inflammation in mice and rats 
 
To confirm the anti-inflammatory effect of DBTL, the mice auricle swelling model 
induced by xylene and the rat foot swelling model caused by adjuvant were established. 
As shown in Fig. 5c and 5d, after administration of DBTL and aspirin, the weight and 
auricle swelling degree of mice in each administration group were all alleviated 
compared with the model group to different degrees (P < 0.01 & P < 0.05). Likewise, 
the foot swelling of rat was significantly lower than the model group (P < 0.01 & P < 
0.05).  
 Fig. 5. DBTL alleviated pain and inflammation in mice and rats in model control group, positive control 
group (aspirin), DBTL groups. (a) The number of twisting induced by glacial acetic acid. *p<0.05, 
**p<0.01 versus model group (b) The change of incubation period of the licking feet time of mice induced 
by hot plate. *p<0.05, **p<0.01 versus model group (c) The change of right ear weight of mice. *p<0.05, 
**p<0.01 versus model group (d) The change of foot swelling of rats. *p<0.05, **p<0.01 versus model 




UTI also known as urinary system infection is the urinary tract epithelium inflammation 
caused by the invasion of bacteria. The pathogenesis of UTI is understood increasingly 
at the level of the uropathogens and the cellular and molecular mediators of host 
inflammatory responses (Bien et al., 2012; Birder and Klumpp, 2016). Women, 
children, and the elderly are highly predisposed to developing UTI (Foxman, 2014). 
Unresolved inflammation during UTI can cause chronic infection and irreversible renal 
damage (Svanborg, 2013; Ulett et al., 2013). Due to its prevalence, frequent recurrence 
and rising resistance to antibiotics, UTI has become a challenge in clinical practice (Gao 
et al., 2017).  
Therefore, Traditional Chinese Medicine which can be used to treat UTI has received 
considerable attention. TCM has clear advantages in treating UTI, especially for 
chronic patients due to its natural nature and minimum side effects. Compared with 
antibiotics, TCM has fewer side effects, do not cause microflora disorders, and are 
inexpensive, suitable for long-term use. DBTL, a Chinese herbal formula, is a hospital 
preparation of Shanghai Seventh People’s Hospital, which has a history of more than 
40 years for the treatment of UTI. In this study, administration with E. coli solution 
induced UTI rat model was used to evaluate the therapeutic effect of DBTL on UTI. 
The UTI patients are usually investigated by performing routine urine examination, and 
some of these indicators have important reference significance. The changes in urine 
pH are closely related to UTI; low pH is beneficial in that it inhibits bacterial growth. 
Urinary tract infection takes hold easily if the urine pH is alkaline, so adjusting the pH 
value is of great significance for the prevention and treatment of UTI (Li-Ping et al., 
2012; Zhou, 2007). Nitrites are important in the diagnosis and detection of urinary 
system diseases because they result from microorganisms that reduce nitrate to nitrous 
acid in urine, something that occurs especially in the UTI. In normal urine, urinary 
nitrite is negative because of the absence of bacteria, while positive in patients with UTI 
(liao, 2012; Ma et al., 2007). Urine bacteria and white blood cell (WBC) detection are 
also the main basis for the diagnosis of UTI. Combining urine culture with WBC counts 
significantly increases the diagnostic rate (Sun et al., 2012).  After treatment with DBTL, 
the pH value was increased; the contents of WBC, nitrite, urinary albumin, ketone body, 
bilirubin and occult blood in urine were all reduced in UTI rats and the urine was 
negative for bacteria in the DBTL groups. These results indicate that DBTL has a great 
therapeutic effect in the treatment of UTI. 
Inflammation is a defining feature of the most common form of clinical UTI and is a 
common symptom observed during UTI (Hooton, 2012; Rudick et al., 2010). Although 
the inflammatory response is triggered to clear pathogens, there's a lot of damage to 
host tissue. E. coli  is the primary cause of UTI in healthy people (Foxman, 2010; 
Hooton, 2012). The results confirmed that DBTL has a significant therapeutic effect on 
UTI and anti-inflammatory effect. H&E staining of renal tissue also showed that DBTL 
could alleviate the degree of inflammation in mice.  
10 compounds were identified from DBTL, including phellodendrine, isochlorogenic 
acid, hesperidin, and so on. Phellodendrine ameliorated the ROS-mediated 
inflammatory response. Li et al. found that AAPH caused a significant increase in the 
production of reactive oxygen species (ROS), lipid-peroxidation and cell death rate, all 
of which could be decreased after treating with phellodendrine  dose-dependently(Li et 
al., 2016). Iso-chlorogenic acid A has great antioxidant and anti-inflammatory activities. 
It reduced the number of macrophages in zebrafish induced by CuSO4 in the 
experimental concentration range (5-40 pg/ml) (Hou et al., 2016). Hu et al. found the 
chlorogenic acid extract had obvious antibacterial activity against shigella dysenteriae 
and staphylococcus aureus (Hu et al., 2010). Chlorogenic acid could also treat septic 
arthritis caused by candida albicans, and its mechanism might be related to the 
inhibition of NO production and proliferation of T cells. Hesperidin had a significant 
inhibitory effect on secondary inflammation in rats (Li et al., 2006), and it was related 
to the regulation of abnormal immune function and maintenance of cytokine network 
balance. Therefore, the effect of DBTL on urinary tract infection in rats and anti-
inflammatory may be closely related to these compounds, which can be further studied 
later. 
The UTI is not only accompanied by some degree of inflammation, but it also causes 
the corresponding pain. The bladder urothelium is considered a mediator of sensory 
responses and appears to play a role in UTI pain responses. Pathogenic factors of 
uropathogens induce urothelial damage that could cause pain due to compromised 
bladder-barrier function (R et al., 2005; Rosen and Klumpp, 2014; Stemler et al., 2013). 
In addition, bacterial glycolipids are the major determinants of UTI pain independent 
of urothelial damage. In summary, UTI pain is a complex form of visceral pain, and its 
specific mechanism needs further investigation (Birder and Klumpp, 2016). Also, it was 
observed in this study that the DBTL can increase the latent period of foot licking 
induced by hot plate method and reduce the number of twisting induced by glacial acetic 
acid in mice, suggesting that DBTL displays an analgesic effect.  
To sum up, UTI is a common but complex disease, and there is no complete specific 
treatment available. In this study, the UTI model in rats was established to evaluate the 
effect of DBTL on UTI. The results show that DBTL has an excellent therapeutic effect 
on UTI and furthermore displays anti-inflammation and analgesic effects. The data 
presented in this study provides a new idea and method for the treatment of UTI and 
lays the foundations for further investigation in the treatment of UTI. 
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